Manhattan Associates

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MANH and other ETFs, options, and stocks.

About MANH

Manhattan Associates, Inc. engages in the business of developing, selling, deploying, servicing, and maintaining software solutions designed to manage supply chains, inventory, and omnichannel operations for retailers, wholesalers, manufacturers, logistics providers, and other organizations. It operates through the following geographical segments: North and Latin America, Europe, Middle East, and Africa, and Asia Pacific. 

CEO
Eric A. Clark
CEOEric A. Clark
Employees
4,370
Employees4,370
Headquarters
Atlanta, Georgia
HeadquartersAtlanta, Georgia
Founded
1990
Founded1990
Employees
4,370
Employees4,370

MANH Key Statistics

Market cap
8.41B
Market cap8.41B
Price-Earnings ratio
38.15
Price-Earnings ratio38.15
Dividend yield
Dividend yield
Average volume
1.33M
Average volume1.33M
High today
$143.35
High today$143.35
Low today
$137.77
Low today$137.77
Open price
$139.79
Open price$139.79
Volume
975.32K
Volume975.32K
52 Week high
$247.22
52 Week high$247.22
52 Week low
$127.86
52 Week low$127.86

Stock Snapshot

Manhattan Associates(MANH) stock is priced at $140.45, giving the company a market capitalization of 8.41B. It carries a P/E multiple of 38.15.

On 2026-02-13, Manhattan Associates(MANH) stock moved within a range of $137.77 to $143.35. With shares now at $140.45, the stock is trading +1.9% above its intraday low and -2.0% below the session's peak.

Trading volume for Manhattan Associates(MANH) stock has reached 975.32K, versus its average volume of 1.33M.

The stock's 52-week range extends from a low of $127.86 to a high of $247.22.

The stock's 52-week range extends from a low of $127.86 to a high of $247.22.

MANH News

Simply Wall St 14h
Assessing Manhattan Associates Valuation After PharmaCare’s SaaS Distribution Network Upgrade

Manhattan Associates (MANH) is back in focus after announcing that PharmaCare upgraded its ANZ distribution network with the Manhattan SCALE platform, citing ga...

Assessing Manhattan Associates Valuation After PharmaCare’s SaaS Distribution Network Upgrade
Simply Wall St 5d
Should Manhattan Associates’ 2026 Revenue and Margin Guidance Prompt Action From MANH Investors?

Manhattan Associates recently reported its fourth-quarter and full-year 2025 results, with revenue of US$270.39 million for the quarter and US$1.08 billion for...

Should Manhattan Associates’ 2026 Revenue and Margin Guidance Prompt Action From MANH Investors?

Analyst ratings

80%

of 15 ratings
Buy
80%
Hold
20%
Sell
0%

People also own

Based on the portfolios of people who own MANH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.